Literature DB >> 23638231

Mucinous borderline tumor involving fallopian tube: case report and review of the literature.

Fangfang Liu1, Junjian Wei, Danhua Shen, Jinsong Liu.   

Abstract

We report the case of a 74-year-old woman with a primary mucinous borderline tumor of the fallopian tube coexisting with an ovarian mucinous borderline tumor. Data were obtained through histopathologic study of the excised surgical specimen. p53, estrogen receptor (ER) and PAX8 expression were evaluated by immunohistochemistry on the available right fallopian tube and ovary. Both the ovarian and fallopian tube borderline ovarian tumors were negative for p53, ER and PAX8. However, the staining pattern highlighted the transition from a normal ciliated cell to neoplastic epithelia in the fallopian tube fimbria. This is the first report to indicate that mucinous borderline tumors may arise from the ciliated cells at the fallopian tube fimbrial epithelia. ER and PAX8 are useful markers in identifying the transition and origination of these tumors.

Entities:  

Keywords:  Fallopian tube ciliated cells; immunohistochemistry; primary mucinous borderline tumor

Mesh:

Year:  2013        PMID: 23638231      PMCID: PMC3638110     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  8 in total

1.  Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.

Authors:  Weiwei Shan; Imelda Mercado-Uribe; Jing Zhang; Daniel Rosen; Shiwu Zhang; Jianjun Wei; Jinsong Liu
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.

Authors:  Eleanor Y Chen; Karishma Mehra; Mitra Mehrad; Gang Ning; Alexander Miron; George L Mutter; Nicholas Monte; Bradley J Quade; Frank D McKeon; Yosuf Yassin; Wa Xian; Christopher P Crum
Journal:  J Pathol       Date:  2010-09       Impact factor: 7.996

Review 4.  Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.

Authors:  Neeraj Lalwani; Srinivasa R Prasad; Raghunandan Vikram; Alampady K Shanbhogue; Phyllis C Huettner; Najla Fasih
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

Review 5.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

6.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

7.  Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.

Authors:  Shannon Salvador; Allan Rempel; Robert A Soslow; Blake Gilks; David Huntsman; Dianne Miller
Journal:  Gynecol Oncol       Date:  2008-07-01       Impact factor: 5.482

8.  Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

Authors:  Michael H Roh; David Kindelberger; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.